Bristol Myers Squibb EPS - Earnings per Share 2010-2024 | BMY

Bristol Myers Squibb earnings per share (EPS) for the twelve months ending September 30, 2024 was $-3.59, a 191.12% decline year-over-year.

  • Bristol Myers Squibb EPS for the quarter ending September 30, 2024 was $0.60, a 35.48% decline year-over-year.
  • Bristol Myers Squibb 2023 annual EPS was $3.86, a 30.85% increase from 2022.
  • Bristol Myers Squibb 2022 annual EPS was $2.95, a 5.45% decline from 2021.
  • Bristol Myers Squibb 2021 annual EPS was $3.12, a 178.2% decline from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.

Bristol Myers Squibb EPS - Earnings per Share 2010-2024 | BMY

  • Bristol Myers Squibb EPS for the quarter ending September 30, 2024 was $0.60, a 35.48% decline year-over-year.
  • Bristol Myers Squibb 2023 annual EPS was $3.86, a 30.85% increase from 2022.
  • Bristol Myers Squibb 2022 annual EPS was $2.95, a 5.45% decline from 2021.
  • Bristol Myers Squibb 2021 annual EPS was $3.12, a 178.2% decline from 2020.

Earnings per share can be defined as a company's net earnings or losses attributable to common shareholders per diluted share base, which includes all convertible securities and debt, options and warrants.